Clinical Trial Update: Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cryoablation in combination with sintilimab and lenvatinib for advanced intrahepatic cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• LENVIMA (lenvatinib)
• Tyvyt (Sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: COMPLETED